ArticleFrontiers in immunology2022

Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Mingyue Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.